Vardit Ravitsky | |
---|---|
![]() | |
Born | Jerusalem, Israel |
Nationality | Israeli and Canadian |
Occupation(s) | Bioethicist, researcher, author |
Title | President and CEO of The Hastings Center |
Awards | Fellow, Canadian Academy of Health Sciences Fellow, Pierre Elliott Trudeau Foundation Fellow, Hastings Center |
Academic background | |
Education | B.A., Philosophy, Sorbonne University, France M.A., Philosophy, University of New Mexico, USA Ph.D., Philosophy, Bar-Ilan University, Israel Post-Doctoral Fellow, NIH, USA |
Alma mater | Bar-Ilan University |
Thesis | Genetic Intervention and the Shaping of Human Identity |
Academic work | |
Institutions | Department of Medical Ethics,School of Medicine,University of Pennsylvania,USA (2005-2008) Department of Social and Preventive Medicine,School of Public Health,University of Montreal (2009 –present) Harvard Medical School,Harvard University (2021-present) |
Vardit Ravitsky is a bioethicist,researcher,and author. She is president and CEO of The Hastings Center,a full professor at the University of Montreal,and a senior lecturer on Global Health and Social Medicine at Harvard Medical School. She is immediate-past president and current vice-president of the International Association of Bioethics,and the director of Ethics and Health at the Center for Research on Ethics. She is a Fellow of the Pierre Elliott Trudeau Foundation,where she chaired the COVID-19 Impact Committee. [1] [2] She is also Fellow of The Hastings Center and of the Canadian Academy of Health Sciences. [3]
Ravitsky has published over 200 research articles and commentaries in bioethics,with a focus on the ethical,social,and policy implications of genomics and reproductive technologies. She leads several research projects,funded by the National Institutes of Health and by Canada's national and provincial funding agencies,and has been awarded a McConnell-University of Montreal Research Chair. She is lead editor of the Penn Center Guide to Bioethics. [4]
Ravitsky holds a bachelor's degree in philosophy from the Sorbonne University in Paris,France and a master's degree in philosophy from the University of New Mexico in Albuquerque,USA. In 2004,she completed her Ph.D. in philosophy with a specialization in Bioethics at Bar-Ilan University in Israel. From 2003 to 2005 Ravitsky was a Post-Doctoral Fellow at the Department of Clinical Bioethics of the National Institutes of Health and at the Social and Behavioral Research Branch of the National Human Genome Research Institute in Bethesda,Maryland,USA. [5]
Ravitsky was a researcher at the Unit for Health Rights and Ethics of the Gertner Institute for Epidemiology and Health Policy Research in Israel (2001-2003). In 2005,she accepted a position as assistant professor at Department of Medical Ethics in the School of Medicine of the University of Pennsylvania. In 2009,she joined the University of Montreal as an assistant professor. She was promoted to associate professor in 2014 and to Full Professor in 2020. [5]
Ravitsky served as a Consultant to Genome Canada (2006-2008),assisting in the development of its GE3LS research program (Genomics and its ethical,environmental,economic,legal,and social implications). From 2008 to 2009 she was senior policy advisor at the Ethics Office of the Canadian Institutes of Health Research (CIHR). In 2018,she was appointed board member of the Canadian Philosophical Association and member of the Genomics &Society Working Group of the National Human Genome Research Institute (NHGRI). In 2020,she was featured by Genome Canada as a leading Canadian researcher in the area of ethical,social,and policy implications of genomics. [6]
Ravitsky's research focuses on reproductive ethics and the ethics of genetics and genomics,often targeting new and potentially disruptive technologies. She has studied the implications of emerging biotechnologies for women's reproductive autonomy,patients’lived experiences,disability rights,and the governance needed to address ethical challenges in these areas. Her research also addresses societal and cultural dimensions of bioethical dilemmas and health policy. [7]
Ravitsky's research is published in academic bioethics journals,as well as clinical journals. Her work explores subjects such as Non-Invasive Prenatal Testing (NIPT),In-Vitro Fertilization (IVF) and pre-implantation genetic testing (PGT),germline gene editing,mitochondrial replacement therapy,gamete donation,epigenetics,the status of frozen embryos,posthumous reproduction,and public health approaches to infertility. [7]
Ravitsky has written about the potential medical and psycho-social issues facing individuals born from gamete (sperm and egg) donation. [8] She argued that their interests to have access to information about their genetic origins should be recognized. [9] She also explored the implications of these interests in the context of cross-border assisted reproduction,where gametes and prospective parents may come from different countries. [10]
Ravitsky's research explores various aspects of assisted reproductive technologies (ART). She studied the need for a public health approach to infertility prevention,particularly in the context of advanced maternal age [11] and in the area of male infertility. She analyzed ethical issues related to fertility preservation in pediatric cancer patients,such as prepubescent girls and adolescents. She also studied issues related to post-humous reproduction,such as consent to the use of leftover embryos from In-Vitro Fertilization (IVF) [12] or factors influencing decision-making regarding the post-humous use of sperm. She studied ethical issues related to access to IVF of women with mental illness and to possible epigenetic risks of IVF. [13]
In 2009,Ravitsky started exploring the socio-ethical aspects of Non-Invasive Prenatal Testing (NIPT),also known as prenatal cell-free DNA testing. She published a paper in Nature Reviews Genetics , [14] arguing that NIPT ought to be implemented without delay due to its potential benefit for pregnant women. In 2011,she participated in the first international workshop on the ethics of NIPT and in 2015 she co-organized an international workshop,exploring NIPT in the Non-Western Context, [15] as well as a workshop at the International Society for Prenatal Diagnosis‘International Conference,in which patients’advocates discussed the impact of NIPT on their families and communities.
Since 2013,Ravitsky has co-led the pan-Canadian research project PEGASUS that explores the responsible implementation of NIPT in the Canadian context. She leads a team of researchers studying the ethical,social,and policy issues associated with NIPT,with a focus on the reproductive autonomy of pregnant people and the need to address disability rights when implementing a new prenatal testing technology. She published extensively on these topics. [16] In 2017,she published a paper proposing a conceptual framework for the ethical analysis of NIPT,based on the tension between women's reproductive autonomy and a public health approach to prenatal testing. [17] In 2021 she led the publication of a paper on the emergence and global spread of NIPT. [18]
Ravitsky has explored various ethical and legal challenges associated with genetic research and genomics-based technologies. In 2006,she published a paper proposing a framework for the disclosure of individual genetic results to research participants. [19] The paper was selected by Essential Science Indicators from Thomson Reuters as the most-cited paper of 2016 in the research area of Social Sciences. It was also named one of the top 5 most cited papers ever published by the American Journal of Bioethics.
She wrote about the ethical and conceptual challenges emerging from epigenetics and about the clinical implementation of Preimplantation Genetic Testing. Her research addresses ethical and policy issues emerging from germline gene editing [20] and mitochondrial replacement therapy. [21] She is member of a group that has explored the need to revise Canadian policy,in particular Canada's 2004 Assisted Human Reproduction Act,to allow research on human embryos using these technologies. [22] In 2022,Ravitsky won competitive NIH grants to co-lead the ethics module of 2 large data-generation projects (one on cell mapping and the other on voice as a biomarker),funded within the Bridge2AI program that seeks to promote health research based on Artificial Intelligence and Machine Learning. [23] [24]
In 2000,Ravitsky was appointed by the Israeli Minister of Health to an expert committee tasked with drafting legislation that would address end-of-life care of dying patients in Israel. The work of the committee resulted in the Dying Patient Law of 2005,that Ravitsky translated to English and has written several papers about. [25] Her work explores the Jewish cultural approach to end-of-life care and the way in which cultural values shape bioethical and policy debates in various societies. She also wrote about the role culture plays in the context of genomics,for example in relation to cloning and gene editing. [26]
In 2015,Ravitsky was invited to write a background paper for the Nuffield Council on Bioethics on the key clinical,ethical,social,legal and policy issues associated with Non-Invasive Prenatal Testing (NIPT), [27] based on which the council developed a project to explore the topic,resulting in a report. [28] She was also invited to write a paper on the ethical aspects of implementing NIPT for the UK government's National Screening Committee. In 2016 she was invited to present to the Quebec National Assembly regarding ethical aspects of gene editing,and in 2017 she was invited to join an expert group convened by Quebec's Commission on Ethics in Science and Technology to write guidelines on germline gene editing. [29]
During the COVID-19 global pandemic,Ravitsky supported the work of clinical ethicists in the healthcare system and gave hundreds of media interviews to enhance trust in public health measures,including COVID vaccines. In 2020,she was appointed by the Pierre Elliott Trudeau Foundation as chair of its COVID-19 Impact Committee,where she oversaw the publication of 16 op-eds in national newspapers,designed to inform public debate about the social challenges of the pandemic. The committee produced a declaration and a podcast series. [30] In 2022,she received a public outreach award from the University of Montreal for her work. [31]
Ravitsky has given over 400 interviews in print media,radio,TV,and podcasts. She has appeared in radio shows such as The Current and Quirks and Quarks,and in TV shows such as Enquête,Découverte,and Netflix's A User's Guide to Cheating Death. She has written numerous opinion articles for the popular press including CNN Opinion, [32] the Globe and Mail, [33] the National Post, [34] the Toronto Star,Policy Options [35] and Psychology Today.
In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm in vitro. The process involves monitoring and stimulating a patient's ovulatory process,removing an ovum or ova from their ovaries and letting sperm fertilise them in a culture medium in a laboratory. After the fertilised egg (zygote) undergoes embryo culture for 2–6 days,it is transferred by catheter into the uterus,with the intention of establishing a successful pregnancy.
Bioethics is both a field of study and professional practice,interested in ethical issues related to health,including those emerging from advances in biology,medicine,and technologies. It proposes the discussion about moral discernment in society and it is often related to medical policy and practice,but also to broader questions as environment,well-being and public health. Bioethics is concerned with the ethical questions that arise in the relationships among life sciences,biotechnology,medicine,politics,law,theology and philosophy. It includes the study of values relating to primary care,other branches of medicine,ethical education in science,animal,and environmental ethics,and public health.
Preimplantation genetic diagnosis is the genetic profiling of embryos prior to implantation,and sometimes even of oocytes prior to fertilization. PGD is considered in a similar fashion to prenatal diagnosis. When used to screen for a specific genetic disease,its main advantage is that it avoids selective abortion,as the method makes it highly likely that the baby will be free of the disease under consideration. PGD thus is an adjunct to assisted reproductive technology,and requires in vitro fertilization (IVF) to obtain oocytes or embryos for evaluation. Embryos are generally obtained through blastomere or blastocyst biopsy. The latter technique has proved to be less deleterious for the embryo,therefore it is advisable to perform the biopsy around day 5 or 6 of development.
Assisted reproductive technology (ART) includes medical procedures used primarily to address infertility. This subject involves procedures such as in vitro fertilization (IVF),intracytoplasmic sperm injection (ICSI),cryopreservation of gametes or embryos,and/or the use of fertility medication. When used to address infertility,ART may also be referred to as fertility treatment. ART mainly belongs to the field of reproductive endocrinology and infertility. Some forms of ART may be used with regard to fertile couples for genetic purpose. ART may also be used in surrogacy arrangements,although not all surrogacy arrangements involve ART. The existence of sterility will not always require ART to be the first option to consider,as there are occasions when its cause is a mild disorder that can be solved with more conventional treatments or with behaviors based on promoting health and reproductive habits.
Surrogacy is an arrangement,often supported by a legal agreement,whereby a woman agrees to delivery/labour on behalf of another couple or person,who will become the child's parent(s) after birth. People may seek a surrogacy arrangement when a couple does not wish to carry a pregnancy themselves,when pregnancy is medically impossible,when pregnancy risks are dangerous for the intended mother,or when a single man or a male same sex couple wish to have a child.
A designer baby is a baby whose genetic makeup has been selected or altered,often to exclude a particular gene or to remove genes associated with disease. This process usually involves analysing a wide range of human embryos to identify genes associated with particular diseases and characteristics,and selecting embryos that have the desired genetic makeup;a process known as preimplantation genetic diagnosis. Screening for single genes is commonly practiced,and polygenic screening is offered by a few companies. Other methods by which a baby's genetic information can be altered involve directly editing the genome before birth,which is not routinely performed and only one instance of this is known to have occurred as of 2019,where Chinese twins Lulu and Nana were edited as embryos,causing widespread criticism.
Gregory Stock is an American biophysicist,best-selling author,biotech entrepreneur,and the former director of the Program on Medicine,Technology and Society at UCLA’s School of Medicine. His interests lie in the scientific and evolutionary as well as ethical,social and political implications of today's revolutions in the life sciences and in information technology and computers.
The Hastings Center is an independent,nonpartisan bioethics research institute and think tank based in Garrison,New York. It was instrumental in establishing the field of bioethics and is among the most prestigious bioethics and health policy institutes in the world.
The Institute on Biotechnology and the Human Future (IBHF) is an affiliate of the Illinois Institute of Technology (IIT) and is housed at IIT's Chicago-Kent College of Law. The IBHF was founded in 2004 by Lori Andrews,J.D.,and Nigel M. de S. Cameron,Ph.D.,to discuss and analyze the ethical,legal,and social implications of biotechnologies.
The genetics and abortion issue is an extension of the abortion debate and the disability rights movement. Since the advent of forms of prenatal diagnosis,such as amniocentesis and ultrasound,it has become possible to detect the presence of congenital disorders in the fetus before birth. Specifically,disability-selective abortion is the abortion of fetuses that are found to have non-fatal mental or physical defects detected through prenatal testing. Many prenatal tests are now considered routine,such as testing for Down syndrome. Women who are discovered to be carrying fetuses with disabilities are often faced with the decision of whether to abort or to prepare to parent a child with disabilities.
The Nuffield Council on Bioethics is a UK-based independent charitable body,which examines and reports on bioethical issues raised by new advances in biological and medical research. Established in 1991,the Council is funded by the Nuffield Foundation,the Medical Research Council and the Wellcome Trust. The Council has been described by the media as a 'leading ethics watchdog',which 'never shrinks from the unthinkable'.
Ruth Macklin is an American philosopher and retired professor of bioethics.
Christoph Rehmann-Sutter is a philosopher and bioethicist. He is holding a professorship for theory and ethics in biosciences at the Institute for History of Medicine and Science Studies at the University of Lübeck in Germany.
I. Glenn Cohen is a Professor of Law at Harvard Law School. He is also the director of Harvard Law School's Petrie-Flom Center for Health Law Policy,Biotechnology,and Bioethics.
Françoise Elvina BaylisFISC is a Canadian bioethicist whose work is at the intersection of applied ethics,health policy,and practice. The focus of her research is on issues of women's health and assisted reproductive technologies,but her research and publication record also extend to such topics as research involving humans,gene editing,novel genetic technologies,public health,the role of bioethics consultants,and neuroethics. Baylis' interest in the impact of bioethics on health and public policy as well as her commitment to citizen engagement]and participatory democracy sees her engage with print,radio,television,and other online publications.
Human germline engineering is the process by which the genome of an individual is edited in such a way that the change is heritable. This is achieved by altering the genes of the germ cells,which then mature into genetically modified eggs and sperm. For safety,ethical,and social reasons,there is broad agreement among the scientific community and the public that germline editing for reproduction is a red line that should not be crossed at this point in time. There are differing public sentiments,however,on whether it may be performed in the future depending on whether the intent would be therapeutic or non-therapeutic.
S. Matthew Liao is an American philosopher specializing in bioethics and normative ethics. He is internationally known for his work on topics including children’s rights and human rights,novel reproductive technologies,neuroethics,and the ethics of artificial intelligence. Liao currently holds the Arthur Zitrin Chair of Bioethics,and is the Director of the Center for Bioethics and Affiliated Professor in the Department of Philosophy at New York University. He has previously held appointments at Oxford,Johns Hopkins,Georgetown,and Princeton.
Intersex people are born with natural variations in physical and sex characteristics including those of the chromosomes,gonads,sex hormones,or genitals that,according to the UN Office of the High Commissioner for Human Rights,"do not fit the typical definitions for male or female bodies". Such variations may involve genital ambiguity,and combinations of chromosomal genotype and sexual phenotype other than XY-male and XX-female. Preimplantation genetic diagnosis allows the elimination of embryos and fetuses with intersex traits and thus has an impact on discrimination against intersex people.
The He Jiankui affair is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui,who edited the genomes of human embryos in 2018. He became widely known on 26 November 2018 after he announced that he had created the first human genetically edited babies. He was listed in the Time's 100 most influential people of 2019. The affair led to ethical and legal controversies,resulting in the indictment of He and two of his collaborators,Zhang Renli and Qin Jinzhou. He eventually received widespread international condemnation.
Eftychia ("Effy") Vayena is a Greek and Swiss bioethicist. Since 2017 she has held the position of chair of bioethics at the Swiss Institute of Technology in Zurich,ETH Zurich. She is an elected member of the Swiss Academy of Medical Sciences.